XML 43 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jan. 31, 2015
Jan. 31, 2014
Cash Flows from Operating Activities    
Net income $ 1,720us-gaap_NetIncomeLoss $ 709us-gaap_NetIncomeLoss
Adjustments to reconcile net income to net cash provided by (used in) operating activities    
Depreciation 689us-gaap_Depreciation 571us-gaap_Depreciation
Amortization 543us-gaap_AdjustmentForAmortization 366us-gaap_AdjustmentForAmortization
Provision for doubtful accounts receivable 8us-gaap_ProvisionForDoubtfulAccounts 6us-gaap_ProvisionForDoubtfulAccounts
Stock-based compensation 388us-gaap_ShareBasedCompensation 605us-gaap_ShareBasedCompensation
Deferred income taxes (67)us-gaap_DeferredIncomeTaxExpenseBenefit (35)us-gaap_DeferredIncomeTaxExpenseBenefit
(Increase) decrease in:    
Accounts receivable 1,638us-gaap_IncreaseDecreaseInAccountsReceivable 1,164us-gaap_IncreaseDecreaseInAccountsReceivable
Inventories (36)us-gaap_IncreaseDecreaseInInventories (1,854)us-gaap_IncreaseDecreaseInInventories
Prepaid expenses 177us-gaap_IncreaseDecreaseInPrepaidExpense (254)us-gaap_IncreaseDecreaseInPrepaidExpense
Income taxes refundable 0us-gaap_IncreaseDecreaseInIncomeTaxesReceivable 254us-gaap_IncreaseDecreaseInIncomeTaxesReceivable
Increase (decrease) in:    
Accounts payable 730us-gaap_IncreaseDecreaseInAccountsPayable (213)us-gaap_IncreaseDecreaseInAccountsPayable
Accrued expenses (243)us-gaap_IncreaseDecreaseInAccruedLiabilities (940)us-gaap_IncreaseDecreaseInAccruedLiabilities
Deferred revenue (644)us-gaap_IncreaseDecreaseInDeferredRevenue (644)us-gaap_IncreaseDecreaseInDeferredRevenue
Income taxes payable (120)us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable (37)us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable
Net cash provided by (used in) operating activities 4,783us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (302)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash Flows from Investing Activities    
Purchase of property and equipment (393)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (735)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Acquisition of Sterimedix (13,177)us-gaap_PaymentsToAcquireBusinessesGross 0us-gaap_PaymentsToAcquireBusinessesGross
Acquisition of patents and other intangibles (69)us-gaap_PaymentsToAcquireIntangibleAssets (139)us-gaap_PaymentsToAcquireIntangibleAssets
Net cash used in investing activities (13,639)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (874)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash Flows from Financing Activities    
Deferred financing costs (123)us-gaap_PaymentsOfFinancingCosts 0us-gaap_PaymentsOfFinancingCosts
Proceeds from borrowings under the Term Loan Facility 2,750us-gaap_ProceedsFromIssuanceOfLongTermDebt 0us-gaap_ProceedsFromIssuanceOfLongTermDebt
Proceeds from the issuance of common stock 28us-gaap_ProceedsFromIssuanceOfCommonStock 36us-gaap_ProceedsFromIssuanceOfCommonStock
Tax benefit associated with the exercise of non-qualified stock options 16us-gaap_DeferredTaxExpenseFromStockOptionsExercised 25us-gaap_DeferredTaxExpenseFromStockOptionsExercised
Net cash provided by financing activities 2,671us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 61us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Foreign exchange rate effect on cash and cash equivalents (392)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents (133)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
Net decrease in cash and cash equivalents (6,577)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (1,248)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents    
Beginning 15,443us-gaap_CashAndCashEquivalentsAtCarryingValue 12,470us-gaap_CashAndCashEquivalentsAtCarryingValue
Ending $ 8,866us-gaap_CashAndCashEquivalentsAtCarryingValue $ 11,222us-gaap_CashAndCashEquivalentsAtCarryingValue